Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Use Investigation of HALAVEN (HAL03T) - Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas

NCT03058406 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT03058406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03058406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Use Investigation of HALAVEN (HAL03T) - Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas
Lead sponsor
Eisai Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
March 1, 2016
Completion date
November 4, 2018
Enrollment
256 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma, soft tissue